Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a mouth injection cure your dry mouth?

NCT ID NCT07309588

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether injections of a solution containing hyaluronic acid and amino acids (Sunecos-200) can relieve dry mouth caused by low saliva production. One hundred adults with dry mouth for at least 3 months will receive either the injections or no treatment. The goal is to see if the treatment improves saliva flow and quality of life, while monitoring for side effects.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Sunecos-200 (non-crosslinked hyaluronic acid and amino acids solution)
What this could lead to
If it works, this could offer a new way to ease dry mouth and improve comfort for people with low saliva.
What could go wrong
This is an early phase 1/2 trial with only 100 participants, so results may not apply to everyone. The treatment involves injections into the mouth, which may cause pain or side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 1/2

Runs two stages together: safety and dose first, then whether the treatment works.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2025

Expected to finish

Jan 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

38 to 78 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * subjective feeling of dry mouth caused by a lack of saliva for at least 3 month, * informed consent sing by patient, * other complains including difficulty during eating, speaking or swallowing, taste disorders, trouble wearing dentures, the sensation that the tongue is stuck to the palate, bad breath and insomnia, feeling dry mouth at night, which made it difficult or impossible to sleep. Exclusion Criteria: * smoking, * alkohol drinking, * pregnancy, * breast feeding, * diabetes, * immunosuppressive treatment, * neoplastic diseases, * Sjögren disease, * active inflammation in the oral cavity, * participation in other clinical trial in within the last 3 months, * allergy or hipersensitivity to hyaluronic acid or amino acides, * no planned hospital stay during the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Xerostomia due to hyposecretion of salivary gland are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Xerostomia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Department of Periodontology and Oral Mucosa Diseases, Poznan University of Medical Sciences

    Poznan, Greater Poland Voivodeship, 60-812, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.